News – Page 1167 – Endpoints News

Tesaro winds up for FDA pitch as PARP rivals race to the finish line

9 years ago

Takeda will transfer 300 staffers to CRO in ongoing R&D overhaul

9 years ago

Protocols: Tillman Gerngross's Avitide goes back to the well for more venture cash; Novartis leads $17M startup round

9 years ago

Troubled Aveo hit with another setback as investigators shutter PhII

9 years ago

Geron shares plunge as J&J assesses another setback for imetelstat

9 years ago

Celgene’s update on its big Crohn’s drug? Trust us, we’re doing fine

9 years ago

Horizon snaps up rare disease drugs, pipeline, in $800M Raptor buyout

9 years ago

Sanofi is teaming with Verily on a $500M JV aimed at marrying tech with diabetes drugs

9 years ago

Gene editing star CRISPR Therapeutics files for $90M IPO

9 years ago

Protocols: Novan downsizes its IPO; GSK floats idea for government-backed vaccine development

9 years ago

Thumbs Up/Down: Brent Saunders has the right idea on drug pricing, let's support that

9 years ago

Lexicon shares surge as Sanofi touts positive PhIII for their new diabetes drug

9 years ago

J&J advances through PhII with a promising hep C triple and 100% cure rate

9 years ago

Just how confident is Arie Belldegrun about Kite's position in the turbulent CAR-T race? He's glad you asked.

9 years ago

Protocols: Clovis surges as FDA rules out a panel review for rucaparib; suffering Tokai will now consider all options

9 years ago

Bluebird bio adds a key process to pioneering gene therapy as it ramps up a pivotal PhIII

9 years ago

Chrono gets a $47M round for new tech designed to quell tobacco cravings

9 years ago

Pfizer seeds diabetes upstart AnTolRx with cash and an option deal

9 years ago

Stung by patient deaths, a small Juno study points to a Goldilocks formula for CAR-T

9 years ago

GW Pharma spikes as the latest buyout rumors swirl around cannabinoid pipeline

9 years ago

Protocols: Retrophin shares soar on promising Phase II data; FDA readies Keytruda review for lung cancer

9 years ago

The next breakthrough? MSK’s Sadelain ties up with Fate on off-the-shelf CAR-Ts

9 years ago

Celgene is squeezing the trigger on an early FDA filing for key Agios cancer drug

9 years ago

$1.9B in: Moderna blueprints $100M facility, plans to double the pipeline after a $474M megaround

9 years ago

First page Previous page 1164 1165 116611671168 1169 1170 Next page Last page